BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16049383)

  • 1. Cerebrospinal fluid tumor marker levels in predicting response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.
    Kosmas C; Tsavaris NB; Tsakonas G; Soukouli G; Gassiamis A; Mylonakis N; Karabelis A
    Med Sci Monit; 2005 Aug; 11(8):CR398-401. PubMed ID: 16049383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptomeningeal carcinomatosis.
    Grossman SA; Krabak MJ
    Cancer Treat Rev; 1999 Apr; 25(2):103-19. PubMed ID: 10395835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies.
    van den Bent MJ; Lamers CH; van 't Veer MB; Sillevis Smitt PA; Bolhuis RL; Gratama JW
    Ann Hematol; 2002 Apr; 81(4):187-91. PubMed ID: 11976819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical demonstration of carcinoembryonic antigen in cerebrospinal fluid with carcinomatous meningitis from rectal cancer.
    Kobayashi TK; Yamaki T; Yoshino E; Higuchi T; Kamachi M
    Acta Cytol; 1984; 28(4):430-4. PubMed ID: 6380184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis.
    Stockhammer G; Poewe W; Burgstaller S; Deisenhammer F; Muigg A; Kiechl S; Schmutzhard E; Maier H; Felber S; Schumacher P; Gunsilius E; Gastl G
    Neurology; 2000 Apr; 54(8):1670-6. PubMed ID: 10762512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-dimer levels in the cerebrospinal fluid: a marker of central nervous system involvement in neoplastic disease.
    Eclache V; Vu T; Le Roux G
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):321-4. PubMed ID: 7971253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic meningitis: still a diagnostic challenge.
    Hildebrand J; Aoun M
    J Neurol; 2003 Jun; 250(6):653-60. PubMed ID: 12796824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptomeningeal carcinomatosis presenting as eosinophilic meningitis.
    Conrad KA; Gross JL; Trojanowski JQ
    Acta Cytol; 1986; 30(1):29-31. PubMed ID: 3456181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status.
    Glantz MJ; Hall WA; Cole BF; Chozick BS; Shannon CM; Wahlberg L; Akerley W; Marin L; Choy H
    Cancer; 1995 Jun; 75(12):2919-31. PubMed ID: 7773943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of sialic acid in the CSF; in relation to the malignancy and leptomeningeal dissemination].
    Moroki K; Kuratsu J; Yoshioka S; Kohchi M; Uemura S; Matsukado Y; Ushio Y
    No To Shinkei; 1989 Mar; 41(3):305-7. PubMed ID: 2757844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinomatous meningitis: clinical manifestations and management.
    Zachariah B; Zachariah SB; Varghese R; Balducci L
    Int J Clin Pharmacol Ther; 1995 Jan; 33(1):7-12. PubMed ID: 7711996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinomatous meningitis as the initial manifestation of breast cancer.
    Heimann A; Merino MJ
    Acta Cytol; 1986; 30(1):25-8. PubMed ID: 3004079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF infections complicating the management of neoplastic meningitis. Clinical features and results of therapy.
    Trump DL; Grossman SA; Thompson G; Murray K
    Arch Intern Med; 1982 Mar; 142(3):583-6. PubMed ID: 6802096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meningeal carcinomatosis].
    Baiges-Octavio JJ; Huerta-Villanueva M
    Rev Neurol; 2000 Dec 16-31; 31(12):1237-41. PubMed ID: 11205566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis.
    Hovestadt A; Henzen-Logmans SC; Vecht CJ
    Br J Cancer; 1990 Oct; 62(4):653-4. PubMed ID: 2223585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers.
    Chamberlain MC
    Neurology; 1998 Apr; 50(4):1173-5. PubMed ID: 9566421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinomatous meningitis complicating cervical cancer: a clinicopathologic study and literature review.
    Aboulafia DM; Taylor LP; Crane RD; Yon JL; Rudolph RH
    Gynecol Oncol; 1996 Feb; 60(2):313-8. PubMed ID: 8631558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinomatous meningitis in solid tumours.
    Jayson GC; Howell A
    Ann Oncol; 1996 Oct; 7(8):773-86. PubMed ID: 8922190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carcinomatous meningitis revealing a cancer: study of two cases].
    Samet S; Belahsen F; Triki C; Masmoudi H; Jlidi R; Mhiri C
    Tunis Med; 2001 Apr; 79(4):257-60. PubMed ID: 11515489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On carcinomatous meningitis secondary to breast cancer].
    Mercier B
    Presse Med; 2000 Jun; 29(20):1133. PubMed ID: 10901795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.